Works matching IS 00071048 AND DT 2007 AND VI 139 AND IP 3


Results: 27
    1
    2

    Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma.

    Published in:
    British Journal of Haematology, 2007, v. 139, n. 3, p. 425, doi. 10.1111/j.1365-2141.2007.06658.x
    By:
    • Owen A. O'Connor;
    • Hamlin, Paul A.;
    • Portlock, Carol;
    • Moskowitz, Craig H.;
    • Noy, Ariela;
    • Straus, David J.;
    • MacGregor-Cortelli, Barbara;
    • Neylon, Ellen;
    • Sarasohn, Debra;
    • Dumetrescu, Otila;
    • Mould, Diane R.;
    • Fleischer, Martin;
    • Zelenetz, Andrew D.;
    • Sirotnak, Frank;
    • Horwitz, Steven
    Publication type:
    Article
    3

    Book review.

    Published in:
    2007
    By:
    • Stanworth, Simon
    Publication type:
    Book Review
    4
    5
    6
    7
    8
    9
    10
    11

    High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.

    Published in:
    British Journal of Haematology, 2007, v. 139, n. 3, p. 450, doi. 10.1111/j.1365-2141.2007.06818.x
    By:
    • Anja Troeger;
    • Gudowius, Sonja;
    • Escherich, Gabriele;
    • den Boer, Monique L.;
    • Glouchkova, Ludmila;
    • Ackermann, Birgit;
    • Meisel, Roland;
    • Laws, Hans-Juergen;
    • Groeger, Marketa;
    • Wessalowski, Ruediger;
    • Willers, Reinhart;
    • Harbott, Jochen;
    • Pieters, Rob;
    • Goebel, Ulrich;
    • Janka-Schaub, Gritta E.;
    • Hanenberg, Helmut;
    • Dilloo, Dagmar
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.

    Published in:
    British Journal of Haematology, 2007, v. 139, n. 3, p. 464, doi. 10.1111/j.1365-2141.2007.06824.x
    By:
    • van Heeckeren, Willem J.;
    • Fanning, Laura R.;
    • Meyerson, Howard J.;
    • Pingfu Fu;
    • Lazarus, Hillard M.;
    • Cooper, Brenda W.;
    • Tse, William W.;
    • Kindwall-Keller, Tamila L.;
    • Jaroscak, Jennifer;
    • Finney, Marcie R.;
    • Fox, Robert M.;
    • Solchaga, Luis;
    • Forster, Margaret;
    • Creger, Richard J.;
    • Laughlin, Mary J.
    Publication type:
    Article
    23
    24
    25

    Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.

    Published in:
    British Journal of Haematology, 2007, v. 139, n. 3, p. 415, doi. 10.1111/j.1365-2141.2007.06832.x
    By:
    • Curti, Antonio;
    • Tosi, Patrizia;
    • Comoli, Patrizia;
    • Terragna, Carolina;
    • Ferri, Elisa;
    • Cellini, Claudia;
    • Massaia, Massimo;
    • D'Addio, Alessandra;
    • Giudice, Valeria;
    • Di Bello, Cristiana;
    • Cavo, Michele;
    • Conte, Roberto;
    • Gugliotta, Gabriele;
    • Baccarani, Michele;
    • Lemoli, Roberto M.
    Publication type:
    Article
    26
    27